ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Program Manager (Contract) at Umoja Biopharma - ApplyBlast

Senior Program Manager (Contract)

Umoja Biopharma

3 days ago

Seattle, Washington, United States

Onsite

Contract

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Umoja Biopharma is seeking a solutions-oriented temporary Program Manager to lead the execution of development programs in a fast-paced biotech environment. This role provides program and project management across the portfolio, emphasizing cross-functional coordination, IND-enabling activities, and regulatory submissions. The Program Manager ensures that scope, timelines, risks, dependencies, and decisions are clearly defined, actively managed, and communicated.

Responsibilities

Lead day-to-day program and project management for development programs
Develop and maintain integrated program plans covering IND-enabling activities and critical path
Serve as central point of coordination driving alignment across research, clinical, and regulatory partners

Skills

Qualifications

Bachelor's degree in life sciences, engineering, or a related disciplineMasters degree in life sciences, engineering, or related disciplinePhD in life sciences, engineering, or related disciplinePMP or equivalent program/project management certification

About Umoja Biopharma

umoja-biopharma.com

Headquarters

Seattle, Washington, United States

Company Size

51-200 employees

Founded

2019

View Profile

Umoja Biopharma is a biotechnology company advancing in vivo CAR T cell therapies for cancer using its VivoVec platform to generate CAR T cells directly inside a patient’s body. This approach aims to provide immediate drug availability, bypassing the weeks-to-months manufacturing timeline of traditional ex vivo CAR T therapies, and the company maintains in-house manufacturing to scale production and support its clinical pipeline.